You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

prostate specific membrane antigen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)

Enrolling by invitation
  • Prostate Cancer
  • Whole body study and SPECT with [99mTc]Tc-BQ0413
  • Tomsk, Russian Federation
    TomskNRMC
Oct 26, 2023

Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA

Recruiting
  • Prostatic Neoplasms
  • Radical prostatectomy (RP)
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Jul 14, 2023

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Prostate Cancer Trial in United States (PSMA-PET CT)

Not yet recruiting
  • Prostate Cancer
  • PSMA-PET CT
  • Los Angeles, California
  • +3 more
Jul 6, 2023

Prostate Cancer Trial in Leuven (68Ga-PSMA (HBED-CC) PET)

Recruiting
  • Prostate Cancer
  • 68Ga-PSMA (HBED-CC) PET
  • Leuven, Belgium
    UZLeuven
Nov 18, 2022

Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

Recruiting
  • Malignancy
  • Al18F-PSMA-BCH PET/CT
  • Beijing, Chaoyang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023

Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

Not yet recruiting
  • Prostate Cancer
  • Darolutamide Oral Tablet [Nubeqa]
  • (no location specified)
Jun 2, 2023

Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

Active, not recruiting
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 28, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

Active, not recruiting
  • Prostate Cancer
  • +5 more
  • 131I-PSMA-1095 Radioligand Therapy (RLT)
  • Montreal, Quebec, Canada
    Stephan Probst
Oct 24, 2022

Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radionuclide Therapy
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jun 5, 2023

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)

Not yet recruiting
  • Prostate Cancer Diagnosis
  • PSMA PET scan
  • +2 more
  • Los Angeles, California
    VA Greater Los Angeles Healthcare System
Apr 20, 2023

PET/CT Characterization of Treatment Resistance

Recruiting
  • Prostate Cancer
  • F-fluorodeoxyglucose positron emission tomography (FDG PET)
  • prostate-specific membrane antigen positron emission tomography (PSMA PET)
  • Madison, Wisconsin
    University of Wisconsin
Jan 24, 2023

Oligometastatic Prostate Cancer (OMPC) Trial (AAA617)

Not yet recruiting
  • Oligometastatic Prostate Cancer (OMPC)
  • (no location specified)
Jul 3, 2023

Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Dallas (68Ga-PSMA-11, Positron Emission

Available
  • Prostate Cancer
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 27, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 28, 2022

Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)

Recruiting
  • Breast Cancer
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
Oct 18, 2022

Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)

Recruiting
  • Prostate Cancer
  • Recurrent Prostate Cancer
  • F-DCFPyL Injection
  • PSMA PET
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

18F Prostate-specific Membrane Antigen PET/CT in Prostate Cancer

Recruiting
  • Prostatic Neoplasms
  • Positron emission tomography/computerized tomography (PET/CT)
  • Xi'an, Shaanxi, China
    First Affiliate Hospital of Xi'an Jiaotong University
Mar 23, 2022

Prostate Cancer Trial in New York (huJ591)

Active, not recruiting
  • Prostate Cancer
  • New York, New York
    Weill Cornell Medical College
Apr 20, 2022

Prostate Cancer Trial in St Leonards, Perth (177Lu-DOTA-TLX591)

Not yet recruiting
  • Prostate Cancer
  • 177Lu-DOTA-TLX591
  • St Leonards, New South Wales, Australia
  • +1 more
Jul 18, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

Recruiting
  • Salivary Gland Cancer
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 27, 2022